---
title: "Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287106019.md"
description: "Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News"
datetime: "2026-05-20T10:40:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287106019.md)
  - [en](https://longbridge.com/en/news/287106019.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287106019.md)
---

# Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News

Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering | JUNS Stock News

### Related Stocks

- [JUNS.US](https://longbridge.com/en/quote/JUNS.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News](https://longbridge.com/en/news/286772955.md)
- [Enanta Pharma's RSV Bet And Immunology Ambitions](https://longbridge.com/en/news/286895623.md)
- [Relay drug shows early promise against rare blood vessel diseases](https://longbridge.com/en/news/287094432.md)
- [Bristol-Myers Squibb-Anthropic AI Deal Targets Faster Drug Discovery](https://longbridge.com/en/news/287100303.md)
- [GRI Bio Highlights Promising Phase 2a IPF Data, Outlook](https://longbridge.com/en/news/286422240.md)